Tuesday, 27 December 2016

Surprise Drug Approval Is Holiday Gift for Biogen

Biotech stock Biogen gets a boost from early approval of its spine disorder drug.

from WSJ.com: Markets http://ift.tt/2inzmQe
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)